Wuzhou Medical's Chip Dream: How a Shell Proposal Triggered a $400M Buy Order

The most valuable takeaway from this article: A medical consumables company saw both revenue and profits decline, yet managed to trigger a 422 million yuan buy order wall based solely on a cross-industry M&A proposal that didn't even disclose the target assets. This doesn't reflect the attractiveness of the semiconductor industry, but rather the structural hunger of the A-share market for "cross-industry restructuring" narratives.